UPDATE: Citi Downgrades ORIC Pharamceuticals (ORIC) to Neutral
Tweet Send to a Friend
(Updated - March 22, 2022 6:33 AM EDT)
Citi analyst Yigel Nochomovitz downgraded ORIC Pharamceuticals (NASDAQ: ORIC) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigel Nochomovitz downgraded ORIC Pharamceuticals (NASDAQ: ORIC) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
